User profiles for Olga V Zubkova
 | Olga V ZubkovaSenior Scientist VUW, The Ferrier Verified email at vuw.ac.nz Cited by 639 |
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in …
…, DV Shcheblyakov, AI Tukhvatulin, OV Zubkova… - The Lancet, 2021 - thelancet.com
Background A heterologous recombinant adenovirus (rAd)-based vaccine, Gam-COVID-Vac
(Sputnik V), showed a good safety profile and induced strong humoral and cellular immune …
(Sputnik V), showed a good safety profile and induced strong humoral and cellular immune …
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1 …
DY Logunov, IV Dolzhikova, OV Zubkova… - The Lancet, 2020 - thelancet.com
Background We developed a heterologous COVID-19 vaccine consisting of two components,
a recombinant adenovirus type 26 (rAd26) vector and a recombinant adenovirus type 5 (…
a recombinant adenovirus type 26 (rAd26) vector and a recombinant adenovirus type 5 (…
[HTML][HTML] Neutralizing activity of sera from Sputnik V-vaccinated people against variants of concern (VOC: B. 1.1. 7, B. 1.351, P. 1, B. 1.617. 2, B. 1.617. 3) and Moscow …
…, AI Tukhvatulin, DV Shcheblyakov, OV Zubkova… - Vaccines, 2021 - mdpi.com
Since the beginning of the 2021 year, all the main six vaccines against COVID-19 have
been used in mass vaccination companies around the world. Virus neutralization and …
been used in mass vaccination companies around the world. Virus neutralization and …
[HTML][HTML] An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine “Sputnik Light” for prevention of coronavirus …
…, DV Shcheblyakov, OV Zubkova… - The Lancet Regional …, 2021 - thelancet.com
Background While the world is experiencing another wave of COVID-19 pandemic, global
vaccination program is hampered by an evident shortage in the supply of licensed vaccines. …
vaccination program is hampered by an evident shortage in the supply of licensed vaccines. …
[PDF][PDF] Structural insights into intermediate steps in the Sir2 deacetylation reaction
…, KG Hoff, DG Fatkins, A Daines, OV Zubkova… - Structure, 2008 - cell.com
Sirtuin enzymes comprise a unique class of NAD + -dependent protein deacetylases.
Although structures of many sirtuin complexes have been determined, structural resolution of …
Although structures of many sirtuin complexes have been determined, structural resolution of …
Development of bacteriostatic DNA aptamers for salmonella
…, AB Salmina, OV Perianova, OA Zubkova… - Journal of medicinal …, 2013 - ACS Publications
Salmonella is one of the most dangerous and common food-borne pathogens. The overuse
of antibiotics for disease prevention has led to the development of multidrug resistant …
of antibiotics for disease prevention has led to the development of multidrug resistant …
Synthesis of a Targeted Library of Heparan Sulfate Hexa‐to Dodecasaccharides as Inhibitors of β‐Secretase: Potential Therapeutics for Alzheimer's Disease
Heparan sulfates (HS) are a class of sulfated polysaccharides that function as dynamic biological
regulators of the functions of diverse proteins. The structural basis of these interactions, …
regulators of the functions of diverse proteins. The structural basis of these interactions, …
[HTML][HTML] Shotgun ion mobility mass spectrometry sequencing of heparan sulfate saccharides
Despite evident regulatory roles of heparan sulfate (HS) saccharides in numerous biological
processes, definitive information on the bioactive sequences of these polymers is lacking, …
processes, definitive information on the bioactive sequences of these polymers is lacking, …
[HTML][HTML] Retention of neutralizing response against SARS-CoV-2 omicron variant in sputnik V-Vaccinated individuals
…, DV Shcheblyakov, AI Tukhvatulin, OV Zubkova… - Vaccines, 2022 - mdpi.com
The new Omicron variant of SARS-CoV-2, first identified in November 2021, is rapidly spreading
all around the world. Omicron has become the dominant variant of SARS-CoV-2. There …
all around the world. Omicron has become the dominant variant of SARS-CoV-2. There …
Immunogenicity and protectivity of intranasally delivered vector-based heterologous prime-boost COVID-19 vaccine Sputnik V in mice and non-human primates
…, IB Esmagambetov, OV Zubkova… - Emerging Microbes & …, 2022 - Taylor & Francis
Although unprecedented efforts aiming to stop the COVID-19 pandemic have been made
over the past two years, SARSCoV-2 virus still continues to cause intolerable health and …
over the past two years, SARSCoV-2 virus still continues to cause intolerable health and …